2017-11-29 22:28:22 UTC

AGA Institute Guidebook to ABIM Maintenance of Certification: 2017-2018 Update (PDF)

AGA Institute Guidebooks to the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) provides concise one- and two-page monographs linked to each of the questions in the ABIM Gastroenterology Modules for ABIM Recertification. Completion of each annual update is worth 10 MOC points towards ABIM recertification. Actual ABIM SEP Module questions are not included in the guidebooks, but are available upon request from the ABIM.

Medical knowledge modules provide evidence of a commitment to lifelong learning and involvement in periodic self-assessment to guide continuing learning. Each module allows diplomates to perform a diagnostic self-assessment of their strengths and weaknesses in important aspects of the knowledge base underlying each certification area.

This guidebook contains monographs that correspond to all 30 questions in the following ABIM Self-Evaluation Module: 2017–2018 Update in Gastroenterology (Version 17-01).

Who Should Take this Course

This educational activity is intended for board-certified gastroenterologists currently enrolled in the ABIM Maintenance of Certification Program.

About the Author

Amy S. Oxentenko, MD, AGAF (Editor)

MOC Information

The gastroenterology module for ABIM MOC must be requested through www.abim.org and completed by June 30, 2018.

 

More on Maintenance of Certification (MOC)

Final days to save on AGA Postgraduate Course

April 10, 2018

Early bird deadline is April 18 – last chance to save $75.

Overview of the Regulatory Framework and FDA’s Guidance for the Development and Approval of Biosimilar and Interchangeable Products in the US

April 3, 2018

In this on-demand webinar, Sue Lim, MD provides an overview of the background, terminology and general requirements for biosimilar and interchangeable product applications.

The Development and Approval of Inflectra, a Biosimilar to Remicade: Case Presentation

April 3, 2018

In this on-demand webinar, Sue Lim, MD of the FDA provides a general review of the requirements for a biosimilar 351(k) application and discusses the approval process for Inflectra.